Canaccord analyst Matt Bottomley lowered the firm’s price target on Organigram to C$3.75 from C$4 and keeps a Speculative Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OGI:
